EverPoint Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

EverPoint Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.62M	Buy	+100,000	New	+$2.47M	0.05%	311
2015 Q4	–	Sell	-650,000	Closed	-$10.3M	–	575
2015 Q3	$10.3M	Sell	650,000 -150,000	-19%	-$2.4M	0.27%	105
2015 Q2	$11.4M	Buy	800,000 +300,000	+60%	+$5.08M	0.21%	148
2015 Q1	$8.65M	Buy	500,000 +408,600	+447%	+$7.22M	0.16%	191
2014 Q4	$1.64M	Sell	91,400 -1,038,600	-92%	-$16.7M	0.04%	378
2014 Q3	$14.8M	Buy	1,130,000 +230,000	+26%	+$3.1M	0.34%	83
2014 Q2	$12.9M	Buy	+900,000	New	+$11.8M	0.27%	103

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's NXTM Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in NxStage Medical Inc. (NXTM) in Q4 2016: 100,000 shares worth $2.62M. The stake represents 0.05% of the portfolio and ranks #311 among its holdings. This is a return to the name: EverPoint Asset Management previously reported a position in NXTM as recently as Q3 2015.

EverPoint Asset Management first reported a position in NXTM in Q2 2014 and has held it in 7 quarters since. The position peaked at $14.8M in Q3 2014. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

EverPoint Asset Management held 100,000 shares of NxStage Medical Inc. worth $2.62M as of Q4 2016.
NxStage Medical Inc. was a new EverPoint Asset Management position in Q4 2016.
NxStage Medical Inc. made up 0.05% of EverPoint Asset Management's portfolio in Q4 2016, its #311 holding.
EverPoint Asset Management first reported a position in NxStage Medical Inc. in Q2 2014 and has held it in 7 quarters since.
EverPoint Asset Management's NxStage Medical Inc. position peaked at $14.8M in Q3 2014.
170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.